The Minth Group, Zoll Medical and Abiomed-backed medical device developer has raised at least $217m in total after closing additional series D funding.

USF's senior vice-president for research and innovation Paul Sanberg will return to being a distinguished professor in neurosurgery and brain repair.

The eye disease device developer has raised series B funding to advance research originating from University of Colorado's s Sue Anschutz-Rodgers Eye Center.

Pfizer's Breakthrough Growth Initiative has backed the PureTech microbiome spinoff, which will use the cash to finance phase 2 tests of its lead IBD drug candidate.

Heska has agreed to buy the R/GA-backed veterinary telemedicine platform developer in a deal set to close later this quarter.

GlaxoSmithKline has exited the CDS platform operator, which has been purchased by patient care software provider Amalgam Rx for an undisclosed sum.

The Salesforce-backed lending software provider roughly doubled its valuation to $3.3bn in just five months, Coatue and Tiger Global Management co-leading its latest round.

The JF Shea-backed social commerce marketplace priced its shares above the range in an offering valuing it at about $3bn.

The $5.3bn purchase agreed a year ago would have enabled Alphabet, Mastercard, Citi and American Express to exit the banking software producer.

CapitalG invested in the no-code app software provider at a $2.1bn valuation more than five times higher than it was 18 months ago.